Middle East & Africa Digital Biomarkers Market Size & Outlook
The digital biomarkers market in Middle East & Africa is expected to reach a projected revenue of US$ 206.7 million by 2030. A compound annual growth rate of 10.9% is expected of Middle East & Africa digital biomarkers market from 2024 to 2030.
- Healthcare IT
- Digital Health
- Digital Biomarkers Market Outlook
- Digital Health
Revenue, 2023 (US$M)
$100.2
Forecast, 2030 (US$M)
$206.7
CAGR, 2024 - 2030
10.9%
Report Coverage
Middle East & Africa
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the digital biomarkers market
Every figure cited from GVR research
MEA digital biomarkers market highlights
- The MEA digital biomarkers market generated a revenue of USD 100.2 million in 2023.
- The market is expected to grow at a CAGR of 10.9% from 2024 to 2030.
- In terms of segment, wearable was the largest revenue generating type in 2023.
- Mobile based Applications is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 100.2 million |
| Market revenue in 2030 | USD 206.7 million |
| Growth rate | 10.9% (CAGR from 2023 to 2030) |
| Largest segment | Wearable |
| Fastest growing segment | Mobile based Applications |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Wearable, Mobile based Applications, Sensors |
| Key market players worldwide | Amgen Inc, Biogen Inc, Pfizer Inc, ActiGraph, AliveCor, Koneksa Health, Altoida, Empatica, VivoSense, Ixico, Neurotrack, Aural Analytics, Sonde Health, Clario, Imagene AI, Brainomix, Kinsa, Feel Therapeutics |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.9% of the global digital biomarkers market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Europe is the fastest growing regional market and is projected to reach USD 3,585.1 million by 2030.
Key Regions:U.S., UK, Japan, Brazil, South Korea
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Biomarkers Market Scope
Digital Biomarkers Market segmentation & scope
Others
Others
Digital Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Amgen Inc | View profile | 26,700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | www.amgen.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Biogen Inc | View profile | 7,570 | 225 Binney Street, Cambridge, MA, United States, 02142 | www.biogen.com |
| ActiGraph | View profile | 11-50 | Pensacola, Florida, United States, North America | www.actigraphcorp.com |
| AliveCor | View profile | 101-250 | Mountain View, California, United States, North America | alivecor.com |
| Koneksa Health | View profile | 101-250 | New York, New York, United States, North America | www.koneksahealth.com |
| Altoida | View profile | 11-50 | Washington, District of Columbia, United States, North America | www.altoida.com |
| Empatica | View profile | 51-100 | Cambridge, Massachusetts, United States, North America | www.empatica.com |
| VivoSense | View profile | 11-50 | Newport Coast, California, United States, North America | www.vivosense.com/ |
| Ixico | View profile | 51-100 | London, England, United Kingdom, Europe | www.ixico.com |
Middle East & Africa Digital Biomarkers Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Digital Biomarkers Market Outlook will help companies and investors design strategic landscapes.
Wearable was the largest segment with a revenue share of 38.02% in 2023.
Horizon Databook has segmented the Middle East & Africa digital biomarkers market based on wearable, mobile based applications, sensors covering the revenue growth of each sub-segment from 2018 to 2030.
- Middle East & Africa Digital Biomarkers Market Type Outlook (Revenue, USD Million , 2018-2030)
- Wearable
- Mobile based Applications
- Sensors
- Others
- Middle East & Africa Digital Biomarkers Market Clinical Practice Outlook (Revenue, USD Million , 2018-2030)
- Diagnostic digital biomarkers
- Monitoring digital biomarkers
- Predictive and Prognostic digital biomarkers
- Others
- Middle East & Africa Digital Biomarkers Market Therapeutic Area Outlook (Revenue, USD Million , 2018-2030)
- Cardiovascular and metabolic disorders (CVMD)
- Respiratory disorders
- Psychiatric disorders
- Sleep & Movement Disease
- Neurological disorders
- Musculoskeletal disorders
- Others
- Middle East & Africa Digital Biomarkers Market End-Use Outlook (Revenue, USD Million , 2018-2030)
- Healthcare companies
- Healthcare Providers
- Payers
- Others
Reasons to subscribe to Digital Biomarkers Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Digital Biomarkers Market Outlook databook
- Our clientele includes a mix of Digital Biomarkers Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa Digital Biomarkers Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa Digital Biomarkers Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Middle East Africa Digital Biomarkers Market, 2018-2030 (US$M)
MEA digital biomarkers market statistics, by type, 2018-2030 (US$M)
